Retractable Technologies (RVP) Stock Price

Retractable Technologies Price

NYSE AMEX·CLOSED
0.69USD-0.0050 (-0.73 %)
Market closed

Over the last 19 years Retractable Technologies grew revenue by 1.7% annually, reaching 33.05 M USD. Earnings per share have grown at 11.8% per year over the last 12 years. For Retractable Technologies, the net margin of -36.7% is down versus 32.5% a few years ago. At today's price the dividend yield works out to roughly 18.25%. The payout ratio is around 63% of earnings. The stock trades about 10% above its 52-week low.

Retractable Technologies stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Retractable Technologies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Retractable Technologies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Retractable Technologies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Retractable Technologies Stock Price History
DateRetractable Technologies Price
7/13/20260.69 USD
7/10/20260.69 USD
7/9/20260.70 USD
7/8/20260.70 USD
7/7/20260.71 USD
7/6/20260.73 USD
7/2/20260.73 USD
7/1/20260.73 USD
6/30/20260.72 USD
6/29/20260.70 USD
6/26/20260.70 USD
6/25/20260.70 USD
6/24/20260.72 USD
6/23/20260.69 USD
6/22/20260.69 USD
6/18/20260.67 USD
6/17/20260.67 USD
6/16/20260.66 USD
6/15/20260.67 USD
6/12/20260.70 USD
6/11/20260.70 USD
6/10/20260.69 USD
6/9/20260.69 USD
6/8/20260.69 USD
6/5/20260.69 USD
6/4/20260.66 USD
6/3/20260.66 USD
6/2/20260.67 USD
6/1/20260.70 USD
5/29/20260.68 USD
5/28/20260.73 USD
5/27/20260.72 USD
5/26/20260.69 USD
5/22/20260.71 USD
5/21/20260.68 USD
5/20/20260.66 USD
5/19/20260.68 USD
5/18/20260.67 USD
5/15/20260.64 USD
5/14/20260.69 USD
5/13/20260.70 USD
5/12/20260.70 USD
5/11/20260.68 USD
5/8/20260.70 USD
5/7/20260.70 USD
5/6/20260.69 USD
5/5/20260.72 USD
5/4/20260.65 USD
5/1/20260.63 USD
4/30/20260.63 USD
4/29/20260.62 USD
4/28/20260.62 USD
4/27/20260.64 USD
4/24/20260.65 USD
4/23/20260.65 USD
4/22/20260.66 USD
4/21/20260.63 USD
4/20/20260.65 USD
4/17/20260.67 USD
4/16/20260.69 USD
4/15/20260.69 USD
4/14/20260.67 USD
4/13/20260.70 USD
4/10/20260.67 USD
4/9/20260.72 USD
4/8/20260.68 USD
4/7/20260.69 USD
4/6/20260.71 USD
4/2/20260.69 USD
4/1/20260.67 USD
3/31/20260.66 USD
3/30/20260.69 USD
3/27/20260.67 USD
3/26/20260.68 USD
3/25/20260.72 USD
3/24/20260.72 USD
3/23/20260.72 USD
3/20/20260.73 USD
3/19/20260.70 USD
3/18/20260.70 USD
3/17/20260.70 USD
3/16/20260.70 USD
3/13/20260.70 USD
3/12/20260.69 USD
3/11/20260.73 USD
3/10/20260.71 USD
3/9/20260.66 USD
3/6/20260.70 USD
3/5/20260.70 USD
3/4/20260.68 USD
3/3/20260.69 USD
3/2/20260.66 USD
2/27/20260.67 USD
2/26/20260.67 USD
2/25/20260.66 USD
2/24/20260.66 USD
2/23/20260.66 USD
2/20/20260.67 USD
2/19/20260.69 USD
2/18/20260.68 USD
2/17/20260.71 USD
2/13/20260.66 USD
2/12/20260.67 USD
2/11/20260.67 USD
2/10/20260.66 USD
2/9/20260.66 USD
2/6/20260.65 USD
2/5/20260.65 USD
2/4/20260.71 USD
2/3/20260.68 USD
2/2/20260.71 USD
1/30/20260.70 USD
1/29/20260.71 USD
1/28/20260.70 USD
1/27/20260.72 USD
1/26/20260.73 USD
1/23/20260.69 USD
1/22/20260.71 USD
1/21/20260.71 USD
1/20/20260.72 USD
1/16/20260.73 USD
1/15/20260.71 USD
1/14/20260.72 USD
1/13/20260.74 USD
1/12/20260.76 USD
1/9/20260.77 USD
1/8/20260.78 USD
1/7/20260.76 USD
1/6/20260.76 USD
1/5/20260.76 USD
1/2/20260.76 USD
12/31/20250.77 USD
12/30/20250.78 USD
12/29/20250.81 USD
12/26/20250.83 USD
12/24/20250.82 USD
12/23/20250.82 USD
12/22/20250.82 USD
12/19/20250.82 USD
12/18/20250.82 USD
12/17/20250.82 USD
12/16/20250.82 USD
12/15/20250.83 USD
12/12/20250.82 USD
12/11/20250.83 USD
12/10/20250.82 USD
12/9/20250.82 USD
12/8/20250.82 USD
12/5/20250.82 USD
12/4/20250.82 USD
12/3/20250.82 USD
12/2/20250.82 USD
12/1/20250.82 USD
11/28/20250.83 USD
11/26/20250.82 USD
11/25/20250.82 USD
11/24/20250.82 USD
11/21/20250.80 USD
11/20/20250.81 USD
11/19/20250.82 USD
11/18/20250.83 USD
11/17/20250.83 USD
11/14/20250.78 USD
11/13/20250.81 USD
11/12/20250.84 USD
11/11/20250.85 USD
11/10/20250.84 USD
11/7/20250.82 USD
11/6/20250.85 USD
11/5/20250.86 USD
11/4/20250.84 USD
11/3/20250.88 USD
10/31/20250.88 USD
10/30/20250.87 USD
10/29/20250.90 USD
10/28/20250.90 USD
10/27/20250.92 USD
10/24/20250.95 USD
10/23/20250.95 USD
10/22/20250.98 USD
10/21/20251.06 USD
10/20/20250.98 USD
10/17/20250.91 USD
10/16/20250.98 USD
10/15/20250.98 USD
10/14/20250.92 USD
10/13/20250.97 USD
10/10/20250.97 USD
10/9/20251.03 USD
10/8/20250.92 USD
10/7/20250.94 USD
10/6/20250.90 USD
10/3/20250.87 USD
10/2/20250.86 USD
10/1/20250.84 USD
9/30/20250.84 USD
9/29/20250.82 USD
9/26/20250.84 USD
9/25/20250.83 USD
9/24/20250.80 USD
9/23/20250.82 USD
9/22/20250.83 USD
9/19/20250.84 USD
9/18/20250.83 USD
9/17/20250.82 USD
9/16/20250.82 USD
9/15/20250.82 USD
9/12/20250.82 USD
9/11/20250.81 USD
9/10/20250.82 USD
9/9/20250.81 USD
9/8/20250.80 USD
9/5/20250.79 USD
9/4/20250.78 USD
9/3/20250.79 USD
9/2/20250.80 USD
8/29/20250.84 USD
8/28/20250.84 USD
8/27/20250.83 USD
8/26/20250.85 USD
8/25/20250.85 USD
8/22/20250.83 USD
8/21/20250.83 USD
8/20/20250.85 USD
8/19/20250.79 USD
8/18/20250.80 USD
8/15/20250.80 USD
8/14/20250.78 USD
8/13/20250.80 USD
8/12/20250.82 USD
8/11/20250.82 USD
8/8/20250.78 USD
8/7/20250.75 USD
8/6/20250.75 USD
8/5/20250.73 USD
8/4/20250.73 USD
8/1/20250.74 USD
7/31/20250.74 USD
7/30/20250.74 USD
7/29/20250.73 USD
7/28/20250.72 USD
7/25/20250.71 USD
7/24/20250.71 USD
7/23/20250.69 USD
7/22/20250.67 USD
7/21/20250.66 USD
7/18/20250.66 USD
7/17/20250.67 USD
7/16/20250.67 USD
Access this data via the Eulerpool API

Retractable Technologies Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
34.50 M USD
-3.80 M USD
-4.40 M USD
Jan 1, 2018
33.30 M USD
-1.60 M USD
-2.00 M USD
Jan 1, 2019
41.80 M USD
3.00 M USD
2.40 M USD
Jan 1, 2020
81.90 M USD
24.10 M USD
26.60 M USD
Jan 1, 2021
188.40 M USD
72.60 M USD
55.80 M USD
Jan 1, 2022
94.80 M USD
-900,000.00 USD
4.80 M USD
Jan 1, 2023
43.60 M USD
-11.49 M USD
-7.24 M USD
Jan 1, 2024
33.05 M USD
-21.11 M USD
-12.12 M USD

Retractable Technologies Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 6:52 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
39.0036.0032.0033.0030.0034.0029.0029.0034.0033.0041.0081.00188.0094.0043.0033.00
44.44-7.69-11.113.13-9.0913.33-14.7117.24-2.9424.2497.56132.10-50.00-54.26-23.26
33.3333.3331.2533.3333.3335.2934.4834.4829.4130.3034.1545.6850.5329.7920.93-3.03
13.0012.0010.0011.0010.0012.0010.0010.0010.0010.0014.0037.0095.0028.009.00-1.00
-10.001.00-5.00-7.00-3.005.00-4.00-4.00-2.002.0026.0055.004.00-7.00-12.00
-9.09-110.0040.00-57.14-266.67-180.00-50.00-200.001,200.00111.54-92.73-275.0071.43
23.8026.2026.4026.2027.0027.4029.5029.4032.0032.7032.7033.3034.2033.0029.9429.94
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Retractable Technologies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Retractable Technologies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Retractable Technologies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Retractable Technologies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Retractable Technologies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Retractable Technologies stock margins

The Retractable Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Retractable Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Retractable Technologies.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
28.99 %
-11.01 %
-12.75 %
Jan 1, 2018
30.63 %
-4.80 %
-6.01 %
Jan 1, 2019
33.73 %
7.18 %
5.74 %
Jan 1, 2020
45.18 %
29.43 %
32.48 %
Jan 1, 2021
50.64 %
38.54 %
29.62 %
Jan 1, 2022
29.85 %
-0.95 %
5.06 %
Jan 1, 2023
20.89 %
-26.35 %
-16.61 %
Jan 1, 2024
-3.11 %
-63.86 %
-36.66 %

Retractable Technologies Stock Revenue, EBIT, Earnings per Share

The Retractable Technologies earnings per share therefore indicates how much revenue Retractable Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
1.08 USD
-0.12 USD
-0.14 USD
Jan 1, 2018
1.02 USD
-0.05 USD
-0.06 USD
Jan 1, 2019
1.28 USD
0.09 USD
0.07 USD
Jan 1, 2020
2.46 USD
0.72 USD
0.80 USD
Jan 1, 2021
5.51 USD
2.12 USD
1.63 USD
Jan 1, 2022
2.87 USD
-0.03 USD
0.15 USD
Jan 1, 2023
1.46 USD
-0.38 USD
-0.24 USD
Jan 1, 2024
1.10 USD
-0.70 USD
-0.40 USD

Retractable Technologies business model & stock analysis

Retractable Technologies Inc. is a company based in Little Elm, Texas, specializing in the design, manufacturing, and distribution of healthcare safety products. The company was founded in 1994 by Thomas J. Shaw and has played an important role in the field of medical safety technology. The company's business model is simple but effective. It produces and sells safety-related medical products that are crucial for both patients and healthcare professionals. Retractable Technologies Inc. has a variety of patented products in its portfolio to meet the needs of individuals and the healthcare industry as a whole. its comprehensive product range includes safety scalpels, IV catheters, syringes, blood collection lancets, and many other high-quality products. The history of Retractable Technologies Inc. begins with the development of the VanishPoint safety syringe in 1993 by founder Thomas J. Shaw. Unlike traditional syringes, the VanishPoint model has an automatic protective mechanism that retracts the needle inward after use, significantly reducing the risk of needlestick injuries. The product quickly became the company's best-selling product. Over the years, Retractable Technologies Inc. has continuously expanded and improved its product range, focusing on design and innovation to meet the needs of its customers and the healthcare sector as a whole. The company is divided into various segments, all aimed at improving the safety of patients and healthcare professionals. There is the safety scalpel segment, which began in 1999 with the introduction of the safety lancet line in collaboration with the American Diabetes Association. The goal was to develop a painless blood glucose test with previously unmatched safety in the handling of blood collection lancets and personalized drop protection devices. Another important segment of Retractable Technologies Inc. is the syringe category. The focus here is on reducing needlestick injuries and infections when using syringes. The patented safety mechanisms allow doctors, nurses, and other medical personnel to safely operate syringes. These products are available in various sizes to meet the requirements of infants to adults. The IV catheter category is also well positioned, as Retractable Technologies Inc.'s products reduce the number of peripheral infiltrations and catheter-associated bloodstream infections, reduce damage to blood vessels, and provide personalized safety devices. Finally, there is the tuberculin category, which focuses on measuring skin tests and allergic reactions. The category features products with enhanced safety design and is particularly popular among those who rely on this type of testing. Each patient is different and requires a customized solution to reduce the risk of injuries related to medical products. Retractable Technologies Inc. provides its customers with a high level of safety and convenience through its innovative products. The company has become a market leader in the development and manufacture of safe medical products and is committed to meeting customer needs with effective products. With a strong focus on design and innovation, Retractable Technologies Inc. continues to set the standard for safety products throughout the industry.

Retractable Technologies SWOT Analysis

Strengths

Retractable Technologies Inc (RTI) has several key strengths:

  • Strong patent portfolio: RTI owns a vast portfolio of patents, providing a competitive advantage and protecting its innovative retractable needle technology.
  • Quality products: The company is known for manufacturing high-quality medical devices, ensuring safety and reliability for healthcare professionals and patients.
  • Market leadership: RTI is a market leader in the development and production of retractable needle technology, giving it a significant market share and positioning it as a trusted brand in the healthcare industry.
  • Strong distribution network: The company has established strategic partnerships with distributors globally, enabling efficient and widespread distribution of its products.

Weaknesses

Although RTI has various strengths, it also faces some weaknesses:

  • Dependency on a limited product line: RTI primarily focuses on retractable needle technology, which can limit its product diversification and potentially expose the company to market fluctuations.
  • Competition: The medical device industry is highly competitive, and RTI faces competition from other manufacturers who offer similar retractable needle products.
  • Limited marketing budget: Compared to some larger competitors, RTI may have a relatively smaller marketing budget, which could impact its ability to effectively promote its products.

Opportunities

RTI can leverage the following opportunities to drive growth:

  • Increasing demand for safety features: As awareness about needlestick injuries and bloodborne diseases grows, there is a rising demand for retractable needle devices, presenting an opportunity for RTI to expand its customer base.
  • Emerging markets: RTI can explore untapped markets in developing countries, where healthcare infrastructure is expanding, and demand for quality medical devices is on the rise.
  • Technological advancements: The company can invest in research and development efforts to enhance its retractable needle technology further, potentially gaining a competitive edge through improved product performance and features.

Threats

RTI should be cautious of the following potential threats:

  • Regulatory challenges: The medical device industry is subject to stringent regulations, and changes in regulations or compliance requirements could impact RTI's ability to market and sell its products.
  • Intense competition: Competitors could develop similar or superior retractable needle technology, challenging RTI's market position and potentially leading to a loss of market share.
  • Economic factors: Economic downturns or fluctuations in healthcare budgets could affect the purchasing power of healthcare providers, potentially reducing demand for RTI's products.

Retractable Technologies Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Retractable Technologies historical P/E ratio, EBIT multiple, and P/S ratio

Retractable Technologies annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Retractable Technologies shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
32.00 M Stocks
Jan 1, 2018
32.70 M Stocks
Jan 1, 2019
32.70 M Stocks
Jan 1, 2020
33.30 M Stocks
Jan 1, 2021
34.20 M Stocks
Jan 1, 2022
33.00 M Stocks
Jan 1, 2023
29.94 M Stocks
Jan 1, 2024
29.94 M Stocks

Retractable Technologies Dividend History

1 years of dividend payments

YearAnnual DividendYoY ChangePayments
20150.13USD

Retractable Technologies dividend payout ratio

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2017
62.50 %
Jan 1, 2018
62.50 %
Jan 1, 2019
62.50 %
Jan 1, 2020
62.50 %
Jan 1, 2021
62.50 %
Jan 1, 2022
62.50 %
Jan 1, 2023
62.50 %
Jan 1, 2024
62.50 %
Price targets and forecasts for Retractable Technologies are not yet available.

EESG©

Eulerpool ESG Scorecard© for the Retractable Technologies stock

0/100
0
Environment
0
Social
0
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Retractable Technologies shareholder structure

% Name
54.85921%
Shaw (Thomas J)
Shaw (Thomas J)
2.87575%
Larios Michele Mitchell
Larios Michele Mitchell
2.25053%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.16368%
Renaissance Technologies LLC
Renaissance Technologies LLC
0.81882%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.51981%
Bridgeway Capital Management, LLC
Bridgeway Capital Management, LLC

Retractable Technologies Executives and Management Board

TS

Mr. Thomas Shaw

(74)

Chairman of the Board, President, Chief Executive Officer, Founder

Compensation1.19 M USD
ML

Ms. Michele Larios

(58)

Vice President, General Counsel, Secretary

Compensation410,350.00 USD
JF

Mr. John Fort

(56)

Chief Financial Officer, Vice President, Treasurer, Director · since 2019

Compensation309,000.00 USD
ML

Mr. Marco Laterza

(77)

Independent Director

Compensation10,000.00 USD
WB

Mr. Walter Bigby

(60)

Independent Director

Compensation9,000.00 USD

Retractable Technologies Supply Chain

Frequently asked questions about Retractable Technologies

Retractable Technologies Inc operates under the business model of manufacturing and marketing safety medical devices. As a company, it specializes in retractable syringes, blood collection devices, and other medical products to prevent accidental needlestick injuries. Retractable Technologies Inc prioritizes safety and aims to provide healthcare professionals with innovative tools that minimize the risk of needle-related injuries. With its extensive product portfolio and focus on safety, Retractable Technologies Inc continues to contribute to the medical industry by promoting a safer and more efficient healthcare environment.